Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Ischemic Heart Disease

Free Subscription Articles published in Heart Retrieve available abstracts of 63 articles: HTML format Text format

Single Articles

October 2018
1. OTTO CM
   Heartbeat: improving outcomes after myocardial infarction.
   Heart. 2018;104:1553-1554.
   PubMed     Text format    
   
   
   September 2018
2. KWOK CS, Walsh MN, Volgman A, Alasnag M, et al
   Discharge against medical advice after hospitalisation for acute myocardial infarction.
   Heart. 2018 Sep 12. pii: heartjnl-2018-313671. doi: 10.1136/heartjnl-2018-313671
   PubMed     Text format     Abstract available
   
   
   
3. OTTO CM
   Heartbeat: Social isolation is associated with increased mortality after acute myocardial infarction or stroke.
   Heart. 2018;104:1471-1473.
   PubMed     Text format    
   
   
   August 2018
4. SANTO K, Singleton A, Rogers K, Thiagalingam A, et al
   Medication reminder applications to improve adherence in coronary heart disease: a randomised clinical trial.
   Heart. 2018 Aug 27. pii: heartjnl-2018-313479. doi: 10.1136/heartjnl-2018-313479
   PubMed     Text format     Abstract available
   
   
   
5. 
   Correction: Twenty-five-year trends in myocardial infarction attack and mortality rates, and case-fatality, in six European populations.
   Heart. 2018;104:e2.
   PubMed     Text format    
   
   
   July 2018
6. KUMAR N
   Does the purported mortality benefit of beta-blocker therapy in heart failure with a preserved ejection fraction apply to patients without prior myocardial infarction?
   Heart. 2018;104:1135.
   PubMed     Text format    
   
   
   June 2018
7. FAHEY JK, Ihdayhid AR, White AJ
   A 42-year-old woman with acute myocardial infarction.
   Heart. 2018 Jun 28. pii: heartjnl-2017-312779. doi: 10.1136/heartjnl-2017-312779
   PubMed     Text format    
   
   
   May 2018
8. DOCHERTY KF, Jhund PS
   Early use of mineralocorticoid receptor antagonists in ST-elevation myocardial infarction: is it ever too early?
   Heart. 2018 May 14. pii: heartjnl-2018-313371. doi: 10.1136/heartjnl-2018-313371
   PubMed     Text format    
   
   
   
9. VANEZIS AP, Arnold JR, Rodrigo G, Lai FY, et al
   Daily remote ischaemic conditioning following acute myocardial infarction: a randomised controlled trial.
   Heart. 2018 May 10. pii: heartjnl-2018-313091. doi: 10.1136/heartjnl-2018-313091
   PubMed     Text format     Abstract available
   
   
   April 2018
10. BEYGUI F, Van Belle E, Ecollan P, Machecourt J, et al
    Individual participant data analysis of two trials on aldosterone blockade in myocardial infarction.
    Heart. 2018 Apr 25. pii: heartjnl-2018-312950. doi: 10.1136/heartjnl-2018-312950
    PubMed     Text format     Abstract available
    
    
    
11. NIJJER SS
    Clinical outcomes of potent antiplatelets compared with clopidogrel in ST elevation myocardial infarction.
    Heart. 2018 Apr 17. pii: heartjnl-2018-312967. doi: 10.1136/heartjnl-2018-312967
    PubMed     Text format    
    
    
    
12. MUNDAL LJ, Igland J, Veierod MB, Holven KB, et al
    Impact of age on excess risk of coronary heart disease in patients with familial hypercholesterolaemia.
    Heart. 2018 Apr 5. pii: heartjnl-2017-312706. doi: 10.1136/heartjnl-2017-312706.
    PubMed     Text format     Abstract available
    
    
    
13. OTTO CM
    Heartbeat: Acute myocardial infarction: one test to diagnose them all?
    Heart. 2018;104:625-627.
    PubMed     Text format    
    
    
    March 2018
14. ENGSTROM T, Nepper-Christensen L, Helqvist S, Klovgaard L, et al
    Danegaptide for primary percutaneous coronary intervention in acute myocardial infarction patients: a phase 2 randomised clinical trial.
    Heart. 2018 Mar 30. pii: heartjnl-2017-312774. doi: 10.1136/heartjnl-2017-312774
    PubMed     Text format     Abstract available
    
    
    
15. JOHNSTONE SR, Isakson BE
    'Gaps' in targeted ischaemic injury therapies in ST-elevation myocardial infarction.
    Heart. 2018 Mar 30. pii: heartjnl-2018-313084. doi: 10.1136/heartjnl-2018-313084
    PubMed     Text format    
    
    
    
16. SEPEHRVAND N, James SK, Stub D, Khoshnood A, et al
    Effects of supplemental oxygen therapy in patients with suspected acute myocardial infarction: a meta-analysis of randomised clinical trials.
    Heart. 2018 Mar 29. pii: heartjnl-2018-313089. doi: 10.1136/heartjnl-2018-313089
    PubMed     Text format     Abstract available
    
    
    
17. HAKULINEN C, Pulkki-Raback L, Virtanen M, Jokela M, et al
    Social isolation and loneliness as risk factors for myocardial infarction, stroke and mortality: UK Biobank cohort study of 479 054 men and women.
    Heart. 2018 Mar 27. pii: heartjnl-2017-312663. doi: 10.1136/heartjnl-2017-312663
    PubMed     Text format     Abstract available
    
    
    
18. EDFORS R, Sahlen A, Szummer K, Renlund H, et al
    Outcomes in patients treated with ticagrelor versus clopidogrel after acute myocardial infarction stratified by renal function.
    Heart. 2018 Mar 24. pii: heartjnl-2017-312436. doi: 10.1136/heartjnl-2017-312436
    PubMed     Text format     Abstract available
    
    
    
19. GRIMALDI-BENSOUDA L, Danchin N, Dallongeville J, Falissard B, et al
    Effectiveness of new antiplatelets in the prevention of recurrent myocardial infarction.
    Heart. 2018 Mar 13. pii: heartjnl-2017-312534. doi: 10.1136/heartjnl-2017-312534
    PubMed     Text format     Abstract available
    
    
    February 2018
20. LAMPREA-MONTEALEGRE JA, McClelland RL, Grams M, Ouyang P, et al
    Coronary heart disease risk associated with the dyslipidaemia of chronic kidney disease.
    Heart. 2018 Feb 22. pii: heartjnl-2017-312794. doi: 10.1136/heartjnl-2017-312794
    PubMed     Text format     Abstract available
    
    
    
21. ELIAS J, van Dongen IM, Ramunddal T, Laanmets P, et al
    Long-term impact of chronic total occlusion recanalisation in patients with ST-elevation myocardial infarction.
    Heart. 2018 Feb 20. pii: heartjnl-2017-312698. doi: 10.1136/heartjnl-2017-312698
    PubMed     Text format     Abstract available
    
    
    
22. GARD A, Lindahl B, Batra G, Hadziosmanovic N, et al
    Interphysician agreement on subclassification of myocardial infarction.
    Heart. 2018 Feb 16. pii: heartjnl-2017-312409. doi: 10.1136/heartjnl-2017-312409
    PubMed     Text format     Abstract available
    
    
    
23. BRAVO CA, Hirji SA, Bhatt DL, Gluud C, et al
    Cochrane corner: complete versus culprit-only revascularisation in ST segment elevation myocardial infarction with multivessel disease.
    Heart. 2018 Feb 8. pii: heartjnl-2017-312857. doi: 10.1136/heartjnl-2017-312857.
    PubMed     Text format    
    
    
    
24. FOO CY, Bonsu KO, Nallamothu BK, Reid CM, et al
    Coronary intervention door-to-balloon time and outcomes in ST-elevation myocardial infarction: a meta-analysis.
    Heart. 2018 Feb 5. pii: heartjnl-2017-312517. doi: 10.1136/heartjnl-2017-312517.
    PubMed     Text format     Abstract available
    
    
    January 2018
25. SINGH D, Bhat R, Kothari SS
    25-year-old man with chest pain.
    Heart. 2018;104:72.
    PubMed     Text format     Abstract available
    
    
    
26. MURPHY A, Johnson CO, Roth GA, Forouzanfar MH, et al
    Ischaemic heart disease in the former Soviet Union 1990-2015 according to the Global Burden of Disease 2015 Study.
    Heart. 2018;104:58-66.
    PubMed     Text format     Abstract available
    
    
    
27. GREY C, Jackson R, Wells S, Wu B, et al
    First and recurrent ischaemic heart disease events continue to decline in New Zealand, 2005-2015.
    Heart. 2018;104:51-57.
    PubMed     Text format     Abstract available
    
    
    December 2017
28. STEWART RAH, Colquhoun DM, Marschner SL, Kirby AC, et al
    Persistent psychological distress and mortality in patients with stable coronary artery disease.
    Heart. 2017;103:1860-1866.
    PubMed     Text format     Abstract available
    
    
    
29. ROUX V, Salaun E, Tribouilloy C, Hubert S, et al
    Coronary events complicating infective endocarditis.
    Heart. 2017;103:1906-1910.
    PubMed     Text format     Abstract available
    
    
    
30. GNANENTHIRAN SR, Kritharides L, D'Souza M, Lowe HC, et al
    Revascularisation compared with initial medical therapy for non-ST-elevation acute coronary syndromes in the elderly: a meta-analysis.
    Heart. 2017;103:1962-1969.
    PubMed     Text format     Abstract available
    
    
    
31. DE CARLO M, Liga R
    Elderly patients with non-ST-elevation acute coronary syndromes: a call for action.
    Heart. 2017;103:1932-1933.
    PubMed     Text format    
    
    
    
32. SAINSBURY PA, Fisher M, de Silva R
    Alternative interventions for refractory angina.
    Heart. 2017;103:1911-1922.
    PubMed     Text format    
    
    
    November 2017
33. DURKO AP, Budde RPJ, Geleijnse ML, Kappetein AP, et al
    Recognition, assessment and management of the mechanical complications of acute myocardial infarction.
    Heart. 2017 Nov 16. pii: heartjnl-2017-311473. doi: 10.1136/heartjnl-2017-311473
    PubMed     Text format    
    
    
    
34. MANGION K, Gao H, Husmeier D, Luo X, et al
    Advances in computational modelling for personalised medicine after myocardial infarction.
    Heart. 2017 Nov 10. pii: heartjnl-2017-311449. doi: 10.1136/heartjnl-2017-311449
    PubMed     Text format     Abstract available
    
    
    
35. BAI L, Li Q, Wang J, Lavigne E, et al
    Increased coronary heart disease and stroke hospitalisations from ambient temperatures in Ontario.
    Heart. 2017 Nov 3. pii: heartjnl-2017-311821. doi: 10.1136/heartjnl-2017-311821.
    PubMed     Text format     Abstract available
    
    
    
36. MATULEVICIENE-ANANGEN V, Rosengren A, Svensson AM, Pivodic A, et al
    Glycaemic control and excess risk of major coronary events in persons with type 1 diabetes.
    Heart. 2017;103:1687-1695.
    PubMed     Text format     Abstract available
    
    
    
37. HOORWEG BB, Willemsen RT, Cleef LE, Boogaerts T, et al
    Frequency of chest pain in primary care, diagnostic tests performed and final diagnoses.
    Heart. 2017;103:1727-1732.
    PubMed     Text format     Abstract available
    
    
    
38. GRAY AM, Murphy J, Altman DG, Benedetto U, et al
    One-year costs of bilateral or single internal mammary grafts in the Arterial Revascularisation Trial.
    Heart. 2017;103:1719-1726.
    PubMed     Text format     Abstract available
    
    
    
39. SILVAIN J, Nguyen LS, Spagnoli V, Kerneis M, et al
    Contrast-induced acute kidney injury and mortality in ST elevation myocardial infarction treated with primary percutaneous coronary intervention.
    Heart. 2017 Nov 1. pii: heartjnl-2017-311975. doi: 10.1136/heartjnl-2017-311975.
    PubMed     Text format     Abstract available
    
    
    
40. DENBY KJ, Clark DE, Markham LW
    Management of Kawasaki disease in adults.
    Heart. 2017;103:1760-1769.
    PubMed     Text format     Abstract available
    
    
    
41. HERRINGTON WG, Bragg F
    Extreme ischaemic heart disease risk in people with type 1 diabetes.
    Heart. 2017;103:1656-1657.
    PubMed     Text format    
    
    
    
42. RAHIMI K, Otto CM
    Heartbeat: Glycaemic control and excess risk of major coronary events in type 1 diabetes.
    Heart. 2017;103:1653-1655.
    PubMed     Text format    
    
    
    October 2017
43. DE MARIA GL, Patel N, Banning AP
    Obstructive left main stem coronary disease: is it time to recommend coronary stenting?
    Heart. 2017 Oct 23. pii: heartjnl-2016-310880. doi: 10.1136/heartjnl-2016-310880
    PubMed     Text format    
    
    
    
44. OTTO CM
    Heartbeat: Virtual histopathology after myocardial infarction.
    Heart. 2017;103:1473-1474.
    PubMed     Text format    
    
    
    
45. OTTO CM
    Heartbeat: Ischemic heart disease risk factors in women.
    Heart. 2017;103:1559-1561.
    PubMed     Text format    
    
    
    
46. ASHER E, Kogan A, Segev A
    Severe upper abdominal pain in a 43-year-old woman.
    Heart. 2017;103:1650.
    PubMed     Text format     Abstract available
    
    
    
47. MADONIS SM, Skelding KA, Roberts M
    Management of acute coronary syndromes: special considerations in women.
    Heart. 2017;103:1638-1646.
    PubMed     Text format    
    
    
    September 2017
48. ZHAO M, Vaartjes I, Graham I, Grobbee D, et al
    Sex differences in risk factor management of coronary heart disease across three regions.
    Heart. 2017 Sep 20. pii: heartjnl-2017-311429. doi: 10.1136/heartjnl-2017-311429
    PubMed     Text format     Abstract available
    
    
    
49. ALBADRI A, Wei J, Mehta PK, Shah R, et al
    Sex differences in coronary heart disease risk factors: rename it ischaemic heart disease!
    Heart. 2017 Sep 20. pii: heartjnl-2017-311921. doi: 10.1136/heartjnl-2017-311921
    PubMed     Text format    
    
    
    August 2017
50. WILSON S, Newby DE
    Predicting long-term bleeding risk after acute coronary syndrome: a step closer to optimising dual antiplatelet therapy duration?
    Heart. 2017;103:1143-1145.
    PubMed     Text format    
    
    
    July 2017
51. TIMMIS A, Roobottom C
    Re: The National Institute for Health and Care Excellence update for stable chest pain: poorly reasoned and risky for patients.
    Heart. 2017;103:1055.
    PubMed     Text format    
    
    
    
52. BRUGALETTA S, Sabate M
    A longer look at trial evidence of bioresorbable vascular scaffolds.
    Heart. 2017;103:1061-1062.
    PubMed     Text format    
    
    
    
53. OTTO CM, Luiz Ribeiro A
    Heartbeat: Anatomy versus physiology for diagnosis of coronary artery disease.
    Heart. 2017;103:969-971.
    PubMed     Text format    
    
    
    June 2017
54. FISHER SA, Doree C, Mathur A, Taggart DP, et al
    Cochrane Corner: stem cell therapy for chronic ischaemic heart disease and congestive heart failure.
    Heart. 2017 Jun 12. pii: heartjnl-2017-311684. doi: 10.1136/heartjnl-2017-311684
    PubMed     Text format    
    
    
    
55. MOSS AJ, Lim KH, Japp AG
    A 49-year-old with chest pain and collapse.
    Heart. 2017;103:968.
    PubMed     Text format    
    
    
    May 2017
56. RAJANI R, Modi B, Ntalas I, Curzen N, et al
    Non-invasive Fractional Flow Reserve using Computed Tomographic angiography: where are we now and where are we going?
    Heart. 2017 May 30. pii: heartjnl-2016-311029. doi: 10.1136/heartjnl-2016-311029
    PubMed     Text format    
    
    
    April 2017
57. CADEMARTIRI F, Nistri S, Tarantini G, Maffei E, et al
    Management of coronary artery disease with cardiac CT beyond gatekeeping.
    Heart. 2017 Apr 26. pii: heartjnl-2016-310473. doi: 10.1136/heartjnl-2016-310473
    PubMed     Text format    
    
    
    
58. THOMPSON LE, Daugherty SL
    Gender disparities in cardiovascular disease prevention.
    Heart. 2017;103:479-480.
    PubMed     Text format    
    
    
    
59. DE SILVA K, Myat A, Cotton J, James S, et al
    Bleeding associated with the management of acute coronary syndromes.
    Heart. 2017;103:546-562.
    PubMed     Text format    
    
    
    January 2017
60. CASSESE S, Xhepa E, Kastrati A
    Biodegradable-polymer drug-eluting stents: back to the future?
    Heart. 2017;103:91-92.
    PubMed     Text format    
    
    
    
61. GIAVARINI A, Kilic ID, Redondo Dieguez A, Longo G, et al
    Intracoronary Imaging.
    Heart. 2017 Jan 5. pii: heartjnl-2015-307888. doi: 10.1136/heartjnl-2015-307888.
    PubMed     Text format    
    
    
    November 2016
62. EISEN A, Bhatt DL
    Optimal duration of dual antiplatelet therapy after acute coronary syndromes and coronary stenting.
    Heart. 2016 Nov 25. pii: heartjnl-2015-309022. doi: 10.1136/heartjnl-2015-309022
    PubMed     Text format    
    
    
    September 2016
63. COCKBURN J, Hildick-Smith D, Trivedi U, de Belder A, et al
    Coronary revascularisation in the elderly.
    Heart. 2016 Sep 14. pii: heartjnl-2015-308999. doi: 10.1136/heartjnl-2015-308999
    PubMed     Text format    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Ischemic Heart Disease is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: